INCY
Incyte Corporation
NASDAQ · Healthcare · Biotechnology · US
$126.75
−0.98%Forward multiples
Based on analyst estimates
- P/E forward
- 43.76x
- P/E 2026E
- 33.94x
- P/E 2027E
- 14.95x
- P/E 2028E
- 14.05x
- P/S forward
- 4.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.59x
- PEG TTM
- 0.25x
- Price / book
- 4.05x
- Price / sales
- 4.41x
- Price / cash flow
- 12.98x
Enterprise value
- Enterprise value
- $21.2B
- EV / sales
- 3.64x
- EV / EBITDA
- 10.38x
- EV / EBIT
- 11.54x
- Market cap
- $25.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026